United BioSource Expands Global Drug Safety Capabilities

Acquisition of HPM (Geneva) SA Increases Capacity and Expertise
BETHESDA, Md.--(Business Wire)--
United BioSource Corporation (UBC) today announced the acquisition of HPM
(Geneva) SA, a Geneva, Switzerland-based provider of drug safety and
pharmacovigilance services, further extending UBC`s reach into the European
market. The acquisition of HPM (Healthcare Project Management) represents a
strategic expansion of UBC`s market-leading safety and risk management services,
which include comprehensive safety reporting, case processing, and integrated
pharmacovigilance services.

"We are very excited to add the vast experience and services of the HPM team to
the UBC family and equally pleased to enhance our growing global presence with
our first office in Switzerland, from which we intend to offer the portfolio of
UBC`s evidence-generating offerings," said Ethan Leder, CEO of United BioSource
Corporation. Leder added, "HPM has deep experience and offers sophisticated
solutions in the operational and regulatory requirements related to drug safety,
particularly with regard to the specific needs of European agencies." Effective
immediately, the Geneva office will be led by Executive Director Véronique
Basch, PharmD and will operate as part of UBC`s global safety and risk
management group. Following a successful career in drug safety with a major
pharmaceutical company, Dr. Basch was responsible for establishing HPM`s drug
safety operations.

"We are very pleased to be part of UBC," said Pierre-André Lauener, MD, Managing
Director and co-founder of HPM. "After building HPM for the past 12 years, we
wanted to find a company with the same commitment to excellence in drug safety
that has made HPM successful. With their expertise in REMS, late stage studies,
and proven operational expertise, UBC is an ideal fit in that regard. We look
forward to supporting our long-established clients with outstanding service and
an even broader set of capabilities."

UBC`s global drug safety and risk management services include the development
and implementation of risk evaluation and mitigation systems (REMS) programs,
performance-linked access systems (PLAS), periodic safety update reporting
(PSUR), risk management plans, case processing, and integrated pharmacovigilance
services. These services are provided with dedicated and integrated resources
around the globe.

About HPM

HPM (Geneva) SA is a pharmaceutical services organization founded in 1997 with
core capabilities in drug safety, pharmacovigilance consultancy and risk
management services. For more information visit www.hpmgeneva.com.

About UBC

UBC accelerates the generation, analysis and communication of real world
evidence by integrating scientific and operational expertise with innovative
technology solutions to support global development and commercialization of
medical products for life science companies.

The company is headquartered in Bethesda, Maryland, with offices located in the
United States, United Kingdom, Europe, Latin America, and Japan. For more
information about UBC, visit www.unitedbiosource.com.

United BioSource Corporation (UBC)
Dan Donovan, 240-644-0421

Copyright Business Wire 2009